Loading…

The Tolerability, Pharmacokinetics and Pharmacodynamics of Increasing Intravenous Doses of 619C89, a Novel Compound for the Acute Treatment of Stroke, in Healthy Volunteers

Saved in:

Bibliographic Details
Published in:	Annals of the New York Academy of Sciences 1995-09, Vol.765 (1), p.324-326
Main Authors:	MERCER, A. J., LAMB, R. J., HUSSEIN, Z., HOBBIGER, S., POSNER, J.
Format:	Article
Language:	English
Subjects:	Blood Pressure - drug effects Cerebrovascular Disorders - drug therapy Dose-Response Relationship, Drug Double-Blind Method Electroencephalography - drug effects Heart Rate - drug effects Humans Infusions, Intravenous Male Metabolic Clearance Rate Neuroprotective Agents - administration & dosage Neuroprotective Agents - pharmacokinetics Neuroprotective Agents - pharmacology Piperazines - administration & dosage Piperazines - pharmacokinetics Piperazines - pharmacology Placebos Pyrimidines - administration & dosage Pyrimidines - pharmacokinetics Pyrimidines - pharmacology Reference Values Respiration - drug effects
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!